Aerobic Dance During Chemotherapy in Breast Cancer Patients With Cognitive Impairment

Launched by THE FIRST AFFILIATED HOSPITAL WITH NANJING MEDICAL UNIVERSITY · Jan 23, 2024

Keywords

ClinConnect Summary

This clinical trial is exploring how aerobic dance might help breast cancer patients who are experiencing memory and thinking problems during chemotherapy. The researchers want to find out if dancing can improve cognitive function—essentially, how well patients think and remember—compared to fast walking and usual care. Participants will be placed into one of three groups: those who will take part in aerobic dance, those who will do fast walking, and those who will receive regular care without extra exercise. Each exercise group will meet for 50 minutes, three times a week, for 12 weeks.

To be eligible for this study, participants need to be women aged 18 to 65 who have been newly diagnosed with certain stages of breast cancer and will begin chemotherapy. They also should have experienced some noticeable decline in their thinking abilities. However, those who already exercise regularly or have certain health conditions, like motor dysfunction or dementia, will not be able to join. This study aims to find effective ways to help manage cognitive difficulties related to breast cancer treatments, potentially leading to better support for patients.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • 18-65 years old
• • Newly diagnosed, histologically confirmed, resected stage I-IIIa BC
• • Scheduled for chemotherapy with Epirubicin+ Cyclophosphamide (EC) regimen
• • Presence of objective cognitive decline
• Exclusion Criteria:
• • Regular exercise habits (exercise at moderate intensity for 30 minutes a day, 3 days a week, for at least 3 months.),
• • Motor dysfunction
• • Alzheimer's disease
• • Vascular dementia